ZURICH Swiss drugmaker Roche lifted its 2019 sales target on Wednesday for the third time this year, helped by newer medicines and as China bought more cancer drugs to treat a disease blamed for a quarter of the nation's annual deaths.
GENEVA A member of Swiss drugmaker Roche's controlling family said on Wednesday that short-term profit maximization has "destroyed the planet" and the world needs a new breed of capitalism putting long-term interests first.
ZURICH Novartis's anti-blindness medicine Beovu has become the latest eye drug to win U.S. Food and Drug Administration approval, giving the Swiss drugmaker a boost in the increasingly competitive market for eye problems among an aging population.
ZURICH Trade wars, Brexit and the simmering Iran conflict are fanning the flames of global uncertainty, stifling industry's readiness to make investments needed to spur productivity, a Swiss National Bank (SNB) policymaker said on Wednesday.
ZURICH Sunrise Communications slashed the size of a rights offer but this failed to secure the support of a major shareholder for its 6.3 billion Swiss franc ($6.35 billion) purchase of Liberty Global's Swiss UPC unit.
ZURICH The Swiss anti-trust authority has approved Sunrise Communications' 6.3 billion Swiss franc ($6.36 billion) takeover of Liberty Global's UPC business, setting up a showdown between the telecoms company and foes of the deal.
ZURICH Switzerland's markets supervisor said on Wednesday it will lodge a criminal complaint against Chinese conglomerate HNA Group for an alleged "serious breach" of disclosure rules over a stake it once held in duty free group Dufry .
ZURICH A British baby's death this year after getting Novartis's gene therapy Zolgensma was not caused by a toxic drug reaction, the Swiss drugmaker said, allaying concerns over the $2.1 million-per-patient treatment's risks.